» Articles » PMID: 15983985

Differences in Colorectal Carcinoma Stage and Survival by Race and Ethnicity

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2005 Jun 29
PMID 15983985
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the United States, blacks with colorectal carcinoma (CRC) presented with more advanced-stage disease and had higher mortality rates compared with non-Hispanic whites. Data regarding other races/ethnicities were limited, especially for Asian/Pacific Islander and Hispanic white subgroups.

Methods: Using data from 11 population-based cancer registries that participate in the Surveillance, Epidemiology and End Results program, the authors evaluated the relation among 18 different races/ethnicities and disease stage and mortality rates among 154,103 subjects diagnosed with CRC from 1988 to 2000.

Results: Compared with non-Hispanic whites, blacks, American Indians, Chinese, Filipinos, Koreans, Hawaiians, Mexicans, South/Central Americans, and Puerto Ricans were 10-60% more likely to be diagnosed with Stage III or IV CRC. Alternatively, Japanese had a 20% lower risk of advanced-stage CRC. With respect to mortality rates, blacks, American Indians, Hawaiians, and Mexicans had a 20-30% greater risk of mortality, whereas Chinese, Japanese, and Indians/Pakistanis had a 10-40 % lower risk.

Conclusions: The authors observed numerous racial/ethnic disparities in the risks of advanced-stage cancer and mortality among patients with CRC, and there was considerable variation in these risks across Asian/Pacific Islander and Hispanic white subgroups. Although the etiology of these disparities was multifactorial, developing screening and treatment programs that target racial/ethnic populations with elevated risks of poor CRC outcomes may be an important means of reducing these disparities.

Citing Articles

Inequalities in colorectal cancer diagnosis by ethnic group: a population-level study in the English National Health Service.

Birch R, Burr N, Taylor J, Downing A, Quirke P, Morris E BMJ Open Gastroenterol. 2025; 12(1).

PMID: 39778976 PMC: 11749721. DOI: 10.1136/bmjgast-2024-001629.


Disparities in Stage at Diagnosis among Hispanic Patients with Gastric Cancer in the United States.

Jeri-Yabar A, Vittini-Hernandez L, Aller-Rojas R, Arias-Reyes F, Dharmapuri S Cancers (Basel). 2024; 16(19).

PMID: 39409928 PMC: 11475899. DOI: 10.3390/cancers16193308.


Patient COUNTS: A pilot navigation program for Asian American cancer patients.

Chu J, Tsoh J, Shariff-Marco S, Allen L, Oh D, Kuo M Asian Am J Psychol. 2024; 15(3):205-212.

PMID: 39387093 PMC: 11460540. DOI: 10.1037/aap0000319.


Colorectal cancer screening participation in First Nations populations worldwide: a systematic review and data synthesis.

Pham L, Clark P, Macdonald G, Thomas J, Dalais C, Fonda A EClinicalMedicine. 2024; 73:102666.

PMID: 38828132 PMC: 11139771. DOI: 10.1016/j.eclinm.2024.102666.


Providers' and survivors' perspectives on the availability and accessibility of surgery in gastrointestinal cancer care.

English N, V Ivankova N, Smith B, Jones B, Herbey I, Rosamond B J Gastrointest Surg. 2024; 28(8):1330-1338.

PMID: 38824070 PMC: 11298309. DOI: 10.1016/j.gassur.2024.05.019.